Genprex GNPX
NASDAQ GNPX
$2.29 +0.20 (+9.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Genprex (GNPX) Gains (Losses) on Sale of Assets & Investments (2023 - 2025)

Updated

Genprex's Non Operating Investment Income was $545.00 in Q4 2024, compared with -$886.00 a year earlier.

Analysis

Genprex (GNPX) Gains (Losses) on Sale of Assets & Investments (2023 - 2025) Analysis & Trends

For FY2024, Non Operating Investment Income at Genprex came in at -$570.00.

  • In earlier years, Non Operating Investment Income was -$18,676 in FY2023.
  • The Q4 2024 figure marks the highest quarterly Non Operating Investment Income since Q2 2023.
  • Per Business Quant data, GNPX's Non Operating Investment Income in the three quarters before Q4 2024 was -$629.00 (Q3 2024), -$620.00 (Q2 2024) and $135.00 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Genprex 988,908.54 -41.15 Mn -423,306.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.00
Dec 31, 2024 545.00
Sep 30, 2024 -629.00
Jun 30, 2024 -620.00
Mar 31, 2024 135.00
Dec 31, 2023 -886.00
Sep 30, 2023 -13,307.00
Jun 30, 2023 2,208.00
Mar 31, 2023 -6,691.00
API Access

Genprex Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GNPX&period=max&api_key=YOUR_API_KEY